
|Videos|August 5, 2016
Dr. Ranee Mehra on the Importance of Symptom Management in Head and Neck Cancer
Author(s)Ranee Mehra, MD
Advertisement
Ranee Mehra, MD, chief of Head and Neck Oncology at Fox Chase Cancer Center, discusses challenges in head and neck cancer.
Symptom management is key in head and neck cancer, said Mehra. A small growth in a tumor can result in significant changes in speech or swallowing function.
The patient population of head and neck cancer is unique in that they really can be very symptomatic from advanced locoregional disease, said Mehra.
As new combinations of therapies are developed, it is important to keep in mind that there is a need for palliative care for these patients through treatment, she added.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
4
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
5




































